BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38744388)

  • 1. TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic cancer cells.
    Gao Y; Hou J; Fei X; Ren L; Lu R; Liu P; Liu S; Zhu C; Wang X; Pan Y
    Cell Signal; 2024 Aug; 120():111227. PubMed ID: 38744388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of transgelin 2 promotes breast cancer metastasis by activating the reactive oxygen species/nuclear factor‑κB signaling pathway.
    Yang L; Hong Q; Xu SG; Kuang XY; Di GH; Liu GY; Wu J; Shao ZM; Yu SJ
    Mol Med Rep; 2019 Nov; 20(5):4045-4258. PubMed ID: 31485630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
    Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MicroRNA-133b suppresses cell proliferation and invasion of esophageal squamous cell carcinoma via downregulating TAGLN2 expression].
    Tang Y; Liu JH; Shi ZX; Li Z; Liu HT; Lu P
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):91-96. PubMed ID: 30862136
    [No Abstract]   [Full Text] [Related]  

  • 5. GABRP Promotes the Metastasis of Pancreatic Cancer by Activation of the MEK/ERK Signaling Pathway.
    Meng Y; Li R; Geng S; Chen W; Jiang W; Li Z; Hao J; Xu Z
    Biochem Genet; 2024 Feb; 62(1):242-253. PubMed ID: 37326897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer.
    Sun Y; Peng W; He W; Luo M; Chang G; Shen J; Zhao X; Hu Y
    J Exp Clin Cancer Res; 2018 Jul; 37(1):166. PubMed ID: 30041673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma.
    Du YY; Zhao LM; Chen L; Sang MX; Li J; Ma M; Liu JF
    J Gastroenterol Hepatol; 2016 Feb; 31(2):384-93. PubMed ID: 26414725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
    Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/ERK pathway.
    Zheng D; Wei Z; Zhang C; Liu W; Gong C; Wu F; Guo W
    Biol Direct; 2024 Apr; 19(1):28. PubMed ID: 38650011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-133b suppresses bladder cancer malignancy by targeting TAGLN2-mediated cell cycle.
    Zhao F; Zhou LH; Ge YZ; Ping WW; Wu X; Xu ZL; Wang M; Sha ZL; Jia RP
    J Cell Physiol; 2019 Apr; 234(4):4910-4923. PubMed ID: 30317571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling.
    Qi ZH; Xu HX; Zhang SR; Xu JZ; Li S; Gao HL; Jin W; Wang WQ; Wu CT; Ni QX; Yu XJ; Liu L
    Int J Oncol; 2018 Apr; 52(4):1105-1116. PubMed ID: 29436617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of TAGLN2 in the regulation of meningioma tumorigenesis and development.
    Pei J; Li P; Zhang ZY; Zhang HL; Gao YH; Wang DY; Zheng Y; Xu X; Cui JZ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):307-313. PubMed ID: 29424888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a.
    Chen B; Li Q; Zhou Y; Wang X; Zhang Q; Wang Y; Zhuang H; Jiang X; Xiong W
    Cell Cycle; 2018; 17(16):1949-1966. PubMed ID: 30300116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of invasion-metastasis mechanism in pancreatic cancer: involvement of tight junction transmembrane protein occludin and MEK/ERK signal transduction pathway in cancer cell dissociation.
    Tan X; Tamori Y; Egami H; Ishikawa S; Kurizaki T; Takai E; Hirota M; Ogawa M
    Oncol Rep; 2004 May; 11(5):993-8. PubMed ID: 15069537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor β and Ras/MEK/ERK signaling regulate the expression level of a novel tumor suppressor Lefty.
    Miyata N; Azuma T; Hozawa S; Higuchi H; Yokoyama A; Kabashima A; Igarashi T; Saeki K; Hibi T
    Pancreas; 2012 Jul; 41(5):745-52. PubMed ID: 22441145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of pituitary tumor transforming gene 1 and transgelin-2 in pancreatic cancer.
    Lin H; Chen QL; Wang XY; Han W; He TY; Yan D; Chen K; Su LD
    Int J Immunopathol Pharmacol; 2013; 26(1):147-56. PubMed ID: 23527717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydrosanguinarine suppresses pancreatic cancer cells via regulation of mut-p53/WT-p53 and the Ras/Raf/Mek/Erk pathway.
    Wu SZ; Xu HC; Wu XL; Liu P; Shi YC; Pang P; Deng L; Zhou GX; Chen XY
    Phytomedicine; 2019 Jun; 59():152895. PubMed ID: 30913453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer.
    Xu J; Wang J; He Z; Chen P; Jiang X; Chen Y; Liu X; Jiang J
    Cell Death Dis; 2021 Jun; 12(7):648. PubMed ID: 34168120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.